undamentalytics Newsletter
Sign in

Maravai Lifesciences Holdings, Inc. balance sheet

At the end of fiscal 2025, Maravai Lifesciences Holdings, Inc. had total assets of $771m, total liabilities of $398m and shareholders' equity of $212m. It held $217m in cash against $294m of debt: net debt of $77.3m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents2523655163257532221770
Receivables—5111813955392531
Inventory—33524351504041
Total current assets—332740848700429296156
Goodwill—224153284326160129129
Total assets—1,2711,9182,2821,4871,008771604
Accounts payable—886—1237
Deferred revenue (current)—78103322—
Total current liabilities—1319411087574538
Short-term debt—6655551
Long-term debt—529525522519290286146
Total debt0550544539533300294150
Total liabilities—1,1161,3731,377698431398248
Shareholders' equity14589315545417325212205
Non-controlling interests and other (assets − liabilities − equity)—66230360373252160151
Net debt (negative = net cash)−25314−7−94−42−237780

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CTKB vs MRVICYRX vs MRVIMLAB vs MRVIMRVI vs SDGR

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Maravai Lifesciences Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Maravai Lifesciences Holdings, Inc.